Skip to main content
SpringerLink
Log in

Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

It has been reported that complete cytoreduction using peritonectomy combined with intraperitoneal chemotherapy improves the prognosis of patients with pseudomyxoma peritonei (PMP); however, this treatment strategy remains controversial, especially at nonspecialized institutes, because of its high morbidity rate.

Methods

We reviewed the clinical records of 15 consecutive patients with PMP, treated in nonspecialized hospitals and observed by one of us between 1999 and 2010. Cytoreductive surgery was done using peritonectomy procedures with intraperitoneal chemotherapy and was performed with curative intent, |in accordance with Sugarbaker.

Results

All patients had mucinous tumors disseminated in the peritoneal cavity. Complete cytoreduction was achieved in 12 patients. Morbidity was 40% (6/15) and mortality was 0% (0/15). After a median follow-up period of 43 months, the 12 patients who underwent complete cytoreduction were disease-free with good quality of life, and 1 of the 3 patients who underwent incomplete cytoreduction was alive with disease.

Conclusions

These findings suggest that peritonectomy with intraperitoneal chemotherapy for PMP can provide prognostic benefit, even at nonspecialized hospitals. Considering the treatment risk, it should ideally be performed at a referral center, or at least by an experienced surgeon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rosai J. Pseudomyxoma peritonei. In: Rosai and Ackerman’s surgical pathology. 9th ed. London: Mosby; 2004. p. 2386–2387, 764–5.

    Google Scholar 

  2. Ronnett BM, Yan H, Kurman RJ, Schmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85–91.

    Article  PubMed  CAS  Google Scholar 

  3. Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathological analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551–559.

    Article  PubMed  Google Scholar 

  4. O’Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 2002;161:551–564.

    Article  PubMed  Google Scholar 

  5. Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P. Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. Health Technol Assess 2004;8(7):1–54.

    Google Scholar 

  6. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14:484–492.

    Article  PubMed  Google Scholar 

  7. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992;70:396–401.

    Article  PubMed  CAS  Google Scholar 

  8. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29–42.

    Article  PubMed  CAS  Google Scholar 

  9. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–731.

    Article  PubMed  CAS  Google Scholar 

  10. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007;245:104–109.

    Article  PubMed  Google Scholar 

  11. Deraco M, Baratti D, Inqlese MG, Allaria B, Andreola S, Gavazzi C, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004;11:393–398.

    Article  PubMed  Google Scholar 

  12. Guner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005;20:155–160.

    Article  PubMed  CAS  Google Scholar 

  13. Van Leeuwen BL, Grat W, Pahlman L, Mahteme H. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 2008;15:745–753.

    Article  PubMed  Google Scholar 

  14. Vaira M, Cioppa Tm DE Marco G, Bing C, D’Aamico S, D’Alessandro M, et al. Management of pseudomyxoma peritonei by cytoreduction + HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. In Vivo 2009;23:639–644.

    PubMed  Google Scholar 

  15. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasm with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 2008;98:277–282.

    Article  PubMed  Google Scholar 

  16. Yonemura Y, Bando E, Kawamura T, Ito H, Endo Y, Miura M, et al. Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 2007;134:357–373.

    PubMed  CAS  Google Scholar 

  17. Yang XJ, Li Y, al-Shammaa Hassan AH, Yang GL Liu SY, Lu XL, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Ann Surg Oncol 2009;16:345–351.

    Article  PubMed  Google Scholar 

  18. Katayama K, Yamaguchi A, Murakami M, Koneri K, Nagano H, Honda K, et al. Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei. Int J Clin Oncol 2009;14:120–124.

    Article  PubMed  CAS  Google Scholar 

  19. Hsu KH, Chou CY, Chang YC. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei. Hepatogastroenterology 2007;54:47–52.

    PubMed  Google Scholar 

  20. Jarvinen P, Jarvinen HJ, Lepisto A. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis 2010;12(9):868–872.

    Article  PubMed  CAS  Google Scholar 

  21. Esquivel J, Sticca R. Sugarbaker PH, Levine E, Yan TD, Alexander R, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancy of colonic origin: a consensus statement. Ann Surg Oncol 2007;14:128–133.

    PubMed  CAS  Google Scholar 

  22. Sugarbaker PH. The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 2002;28:443–446.

    PubMed  CAS  Google Scholar 

  23. Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg 2001;234:198–205.

    Article  PubMed  CAS  Google Scholar 

  24. Chua TC, Yan TD, Yap ZL, Horton MD, Fermanis GG, Morris DL. Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. J Surg Oncol 2009;99:292–295.

    Article  PubMed  Google Scholar 

  25. Suzuki J, Kazama S, Kitayama J, Uozaki H, Miyata T, Nagawa H. Signet ring cell carcinoma of the appendix manifesting as colonic obstruction and ovarian tumors: report of a case. Surg Today 2009;39:235–240.

    Article  PubMed  Google Scholar 

  26. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006;13:615–644.

    Article  Google Scholar 

  27. Kerscher AG, Mallalieu J, Pitroff A, Kerscher F, Esquivel J. Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraoperative chemotherapy (HIPEC) performed at a community hospital. World J Surg 2010;34:62–69.

    Article  PubMed  Google Scholar 

  28. Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2008;51:868–874.

    Article  PubMed  Google Scholar 

  29. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004;240:278–285.

    Article  PubMed  Google Scholar 

  30. Moradi BN, Esquivel J. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2009;100:293–296.

    Article  PubMed  Google Scholar 

  31. Chua TC, Martin S, Sexana A, Liauw W, Yan TD, Zhao J, et al. Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 2010;251:323–329.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawaracho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Toshiyuki Kitai, Masahiro Kawashima & Kenya Yamanaka

  2. Department of Pathology, Nara Social Insurance Hospital, Nara, Japan

    Kunio Ichijima

  3. Department of Surgery, Nara Social Insurance Hospital, Nara, Japan

    Hideaki Fujii, Susumu Mashima & Yasuyuki Shimahara

Authors
  1. Toshiyuki Kitai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiro Kawashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenya Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kunio Ichijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideaki Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susumu Mashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuyuki Shimahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitai, T., Kawashima, M., Yamanaka, K. et al. Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals. Surg Today 41, 1219–1223 (2011). https://doi.org/10.1007/s00595-010-4495-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-010-4495-6

Key words

Search

Navigation